Richard Pin, MD
Vascular Surgery · North Dartmouth, MANPI 1487708202
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.4%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Abbott accounts for 70.6% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $26,631 and has fallen 72.7% since, to $7,269 in 2025. Among vascular surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 326 payments — averaging $223.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$52K
- Penumbra, Inc.$11K
- Boston Scientific$4K
- Contego Medical, Inc$1K
- Medtronic$1K
- Shockwave Medical, Inc$660
- plus $3K from 17 others
Across 206 payments — averaging $3762.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$480K
- Shockwave Medical, Inc$241K
- Penumbra, Inc.$42K
- Contego Medical, Inc$10K
- Philips North America LLC$1K
What the payments were for
- Consulting fees$43,36359%
- Speaking & faculty fees$9,00012%
- Travel & lodging$8,86212%
- Food & beverage$11,75516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 121 | $51,546 |
| Penumbra, Inc. | 38 | $11,121 |
| Boston Scientific | 25 | $4,125 |
| Contego Medical, Inc | 16 | $1,373 |
| Medtronic(2 entities) | 18 | $1,007 |
| Shockwave Medical, Inc | 28 | $660 |
| Silk Road Medical, Inc. | 6 | $505 |
| Cardiovascular Systems Inc. | 6 | $456 |
| Philips North America LLC | 9 | $401 |
| Bolton Medical Inc | 2 | $276 |
| W. L. Gore & Associates, Inc. | 3 | $265 |
| Endologix LLC | 5 | $257 |
| Veryan Medical Incorporated | 4 | $220 |
| Cook Medical LLC | 16 | $154 |
| Getinge USA Sales, LLC | 8 | $145 |
| Inari Medical, Inc. | 6 | $138 |
| Terumo Medical Corporation | 7 | $96 |
| Stryker | 2 | $80 |
| Lemaitre Vascular, Inc. | 1 | $52 |
| EKOS Corporation | 2 | $30 |
| Intact Vascular, Inc. | 1 | $27 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| Pfizer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ESPRIT$13,534
- JETi Peripheral Catheter$11,125
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$10,875
- SUPERA$7,250
- Indigo$4,474
- XIENCE SIERRA$4,125
- GENERAL VASCULAR INTERVENTION$2,724
- Penumbra Ruby Coil$2,677
- Indigo System$2,359
- ANGIO-SEAL$1,456
- Penumbra Coil 400$1,304
- ENROUTE Transcarotid Neuroprotection System$687
- Penumbra System$654
- ENDURANT IIS$542
- Diamondback Peripheral$419
- JETi All In One Non-Sterile Kit$349
- ENHANCE Transcarotid Peripheral Access Kit$335
- TREO ABDOMINAL STENT-GRAFT SYSTEM$276
- INDEFLATOR$250
- ENROUTE Transcarotid Stent System$229
How this compares
$72,979 in reported general payments places this provider in the 95th percentile of 142 vascular surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 82 | $64,804 |
| XareltoRivaroxaban | 28 | $26,976 |
| ClopidogrelClopidogrel Bisulfate | 226 | $2,677 |
| Nitro-BidNitroglycerin | 24 | $2,213 |
| Cilostazol | 44 | $1,639 |
| Pantoprazole Sodium | 46 | $505 |
| Gabapentin | 23 | $202 |
| Oxycodone Hcl | 27 | $152 |
| Methylprednisolone | 16 | $135 |
| Amlodipine Besylate | 24 | $68 |
| Diazepam | 21 | $24 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $18 | $64,80482 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 142 vascular surgery providers in Massachusetts.
Other vascular surgery in North Dartmouth
- Christopher TangaNorth Dartmouth$30K
- David GillespieNorth Dartmouth$13K
- Mark PerryNorth Dartmouth$6K
- Thomas OdonnellBoston$845K
- Scott JamesPlymouth$199K
- Anahita DuaBoston$186K
- Dejah JudelsonWorcester$92K
- Jonathan GertlerWeston$90K
- Andres SchanzerWorcester$84K
- Marc SchermerhornBoston$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.